课题基金 / 基金详情

Genetic Variation in KIBRA and its role in Human Episodic Memory

Genetic Variation in KIBRA and its role in Human Episodic Memory
KIBRA 的遗传变异及其在人类情景记忆中的作用
批准号:
7599012
负责人:
Matt Huentelman
金额:
$34.25万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-01 至 2012-03-31

项目摘要

项目成果

Matt Huentelman的其他基金

相关文献

中文摘要
翻译
描述(由申请人提供):情景记忆包括有意识地回忆所需的自传体经历。 内侧颞叶的区域,包括海马,通常被认为是控制情景记忆形成的关键大脑区域,并且这些区域的退化,例如在阿尔茨海默病期间,通常与记忆丧失有关。 尽管记忆在健康和疾病中起着重要作用,但人们对决定人类记忆表现差异的遗传学知之甚少。 为了确定影响记忆力的遗传因素,我们对瑞士国籍的个体进行了全基因组关联研究,根据记忆力表现进行分层。 位于基因KIBRA中的SNP rs17070145被发现与记忆表现显著相关,随后在两个独立的队列中进行了验证。 表达分析表明,KIBRA转录富集在海马,和功能性MRI研究表明,非载体的rs17070145 T等位基因增加激活的海马在记忆检索。 这些数据表明KIBRA在情景记忆形成中的关键作用,并导致KIBRA的变体存在于记忆表现降低的个体中的假设。 本研究计划的目标是识别这种变体并确定其对KIBRA的影响。 这将通过研究相关单倍型上的生物学相关性SNP、鉴定海马中表达KIBRA的那些细胞并比较单倍型阴性和阳性个体的差异、通过检查记忆调节影响的KIBRA生物学途径的体内抑制剂以及通过基因转移改变海马内KIBRA的表达水平来实现。 拟议的研究将导致对记忆生物学的更全面的理解,希望利用这些信息为那些患有遗忘症的人开发记忆保留药物。 公共卫生相关性以记忆丧失为症状的疾病是常见的和毁灭性的。 目前,我们对记忆的过程知之甚少。 这项研究计划的目标是扩展一项遗传发现,将一种名为KIBRA的蛋白质与记忆表现联系起来,以更好地了解其在记忆过程中的作用,不仅希望进一步加深我们的知识,而且希望开发新药来保护患有阿尔茨海默氏症等遗忘症的个体的记忆功能。
英文摘要
DESCRIPTION (provided by applicant): Episodic memory includes autobiographical experiences that are consciously recalled as desired. Regions of the medial temporal lobe, including the hippocampus, are generally considered to be the key brain regions controlling episodic memory formation, and the degeneration of these regions, such as during Alzheimer's disease, is often associated with memory loss. Despite memory's important role in both health and disease, little is known about the genetics that determine the differences in memory performance in humans. To identify genetic factors influencing memory we performed a whole-genome association study on individuals of Swiss nationality stratified based upon memory performance. SNP rs17070145, located in the gene KIBRA, was found to be significantly associated with memory performance and was subsequently validated in two independent cohorts. Expression analysis indicated that KIBRA transcripts were enriched in the hippocampus, and functional MRI investigation showed that non-carriers of the rs17070145 T allele increased activation of the hippocampus during memory retrieval. These data suggest a crucial role for KIBRA in episodic memory formation and leads to the hypothesis that a variant of KIBRA exists in individuals with lowered memory performance. The goal of this research plan is to identify this variant and determine its impact on KIBRA. This will be achieved by investigating SNPs of biological relevance on the associated haplotype, identifying those cells in the hippocampus that express KIBRA and compare haplotype negative and positive individuals for differences, by examining in vivo inhibitors of the KIBRA biological pathways for memory modulating affects, and by altering the expression levels of KIBRA within the hippocampus through gene transfer. The proposed studies will lead to a more complete understanding of the biology of memory with the hope of leveraging this information to develop memory-sparing pharmaceuticals for those individuals suffering from amnestic disease. PUBLIC HEALTH RELEVANCE Diseases with memory loss as a symptom are common and devastating. We currently understand very little about how the process of memory works. The goal of this research plan is to expand upon a genetic finding linking a protein known as KIBRA to memory performance to better understand its role in the process of memory with the hopes of not only furthering our knowledge but also developing new drugs to preserve memory function in individuals suffering from amnestic diseases like Alzheimer's.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Profiling (MP) Core G
  • 批准号:
    10491870
  • 项目类别:
  • 资助金额:
    $294.17万
  • 财政年份:
    2021
  • 负责人:
    Matt Huentelman
  • 依托单位:
Microglia contribution to disease pathogenesis in C9orf72 ALS/FTD
Immune and inflammatory system changes in SuperAgers
Project 1: MindCrowd: Precision Aging Cognitive Assessment Through a Web-based Network
  • 批准号:
    10491872
  • 项目类别:
  • 资助金额:
    $69.37万
  • 财政年份:
    2021
  • 负责人:
    Matt Huentelman
  • 依托单位: